BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  New Direction and New Leadership for Sio, LEO Pharma

  This week, two biotechnology firms announced new leadership, David Nassif, J.D., and Christophe Bourdon.

  February 1, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Hope Springs Anew in Rett Syndrome as Anavex Trial Confirms Efficacy

  Anavex Life Sciences announced positive topline results from its Phase III AVATAR trial of Anavex 2-73 (blarcamesione) in adult female patients with Rett syndrome.

  February 1, 2022

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Cortexyme Shuffles Executive Leadership Following Clinical Hold

  Cortexyme, Inc. announced changes to its leadership team, including appointing Christopher Lowe as interim chief executive officer.

  February 1, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Life Sciences Companies Leverage New Partnerships Against Severe Diseases

  Various pharmaceutical companies announced collaborations and licensing agreements from January 31 to February 1.

  February 1, 2022

   · 

  4 min read

   · 

  Hayley Shasteen
• 

  BioMidwest

  At 50, Microbiologics is Still Setting the Standard and Inspiring Confidence in Science

  Microbiologics, Inc. commemorated its 50th anniversary in 2021 by playing a key role in helping the world manage the COVID-19 pandemic.

  February 1, 2022

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Genetown

  Proposed Boston Biotech Building Aims to Address Genetown Space Challenges

  The new six-story building they have planned would sit behind the BEAT and occupy approximately 295,000 square feet of the 16.6-acre property.

  February 1, 2022

   · 

  2 min read

   · 

  Claudia Beezhold
• 

  Business

  Pfizer Taps William Pao to Lead Next Development Chapter

  Pfizer announced that Dr. William Pao, M.D., Ph.D., will take on the role of executive vice president and chief development officer as of March 21.

  February 1, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Biogen Commits $30M to Genentech Non-Hodgkin’s Lymphoma Antibody

  Biogen announced it was exercising its option to participate in Genentech’s development of mosunetuzumab under a long-standing collaboration for antibodies targeting CD20.

  February 1, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Milestone Cabenuva Approval Cuts Antiretroviral Dosing by Half

  Recent FDA approval of ViiV Healthcare’s HIV treatment Cabenuva reduced dosing to once every two months.

  February 1, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  With EUA, Novavax Looks to Add Protein-Based Vaccine to U.S. Arsenal

  Novavax is finally submitting an Emergency Use Authorization request to the U.S. Food and Drug Administration for its COVID-19 vaccine candidate, NVX-CoV2373, a protein-based vaccine.

  February 1, 2022

   · 

  3 min read

   · 

  Mark Terry